Expression of Cytokines and Proteases in Mast Cells in the Lesion of Subcapsular Cell Hyperplasia in Mouse Adrenal Glands

Toxicologic Pathology

Volumn 28, Issue 2, 2000, Pages 297-303

  Kim, Jong Soo ^a   Kubota, Hisayo ^a   Nam, Sang Yoon ^a   Doi, Kunio ^b   Saegusa, Junzo ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b NATL INSTITUTE OF INDUSTRIAL HEALTH   (Japan)

Author keywords

adrenal gland; cytokine; Mast cell; mouse; protease; subcapsular cell hyperplasia

Indexed keywords

BASIC FIBROBLAST GROWTH FACTOR; NERVE GROWTH FACTOR; PROTEINASE; STEM CELL FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ADRENAL HYPERPLASIA; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ENZYME SPECIFICITY; FEMALE; MAST CELL; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADRENAL GLANDS; ANIMALS; BONE MARROW CELLS; CHYMASES; CYTOKINES; DNA PRIMERS; GENE EXPRESSION; HYPERPLASIA; MALE; MAST CELLS; MICE; MICE, INBRED STRAINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; SERINE ENDOPEPTIDASES; TRYPTASES;

ANIMALIA;

EID: 0034020086     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/019262330002800209     Document Type: Article

References (59)

1. Abraham SN, Malaviya R. (1997). Mast cells in infection and immunity. Infect Immun 65: 3501-3508.
2. Adachi S., Tsujimura T., Jippo T., Morimoto M., Isozaki K., Kasugai T., Nomura S., Kitamura Y. (1995). Inhibition of attachment between cultured mast cells and fibroblasts by phorbol 12-myristate 13-acetate and stem cell factor. Exp Hematol 23: 58-65.
3. Aye MT, Hashemi S., Leclair B., Zeibdawi A., Trudel E., Halpenny M., Fuller V., Cheng G. (1992). Expression of stem cell factor and c-kit mRNA in cultured endothelial cells, monocytes and cloned human bone marrow stromal cells (CFU-RF). Exp Hematol 20: 523-527.
4. Battegay EJ, Raines EW, Colbert T., Ross R. (1995). TNF-α stimulation of fibroblast proliferation. Dependence on platelet-derived growth factor (PDGF) secretion and alteration of PDGF receptor expression. J Immunol 154: 6040-6047.
5. Brown JK, Tyler CL, Jones CA, Ruoss SJ, Hartman T., Caughey GH (1995). Tryptase, the dominant secretory granular protein in human mast cells, is a potent mitogen for cultured dog tracheal smooth muscle cells. Am J Respir Cell Mol Biol 13: 227-236.
6. Burgess WH, Maciag T. (1989). The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58: 575-606.
7. Cairns JA, Walls AF (1996). Mast cell tryptase is a mitogen for epithelial cells: Stimulation of IL-8 production and intercellular adhesion molecule-1 expression. J Immunol 156: 275-283.
8. Cairns JA, Walls AF (1997). Mast cell tryptase stimulates the synthesis of type I collagen in human lung fibroblasts. J Clin Invest 99: 1313-1321.
9. Claman HN (1993). Mast cells and fibrosis: Hints from graft-versus-host disease and scleroderma. In: The Mast Cell in Health and Disease, Kaliner MA, Metcalfe DD (eds). Dekker, New York, pp 653-667.
10. Compton SJ, Cairns JA, Holgate ST, Walls AF (1998). The role of mast cell tryptase in regulating endothelial cell proliferation, cytokine release, and adhesion molecule expression: Tryptase induces expression of mRNA for IL-1β and IL-8 and stimulates the selective release of IL-8 from human umbilical vein endothelial cells. J Immunol 161: 1939-1946.
11. Dastych J., Metcalfe DD (1994). Stem cell factor induces mast cell adhesion to fibronectin. J Immunol 152: 213-219.
12. Dunn TB (1970). Normal and pathologic anatomy of the adrenal gland of the mouse, including neoplasms. J Natl Cancer Inst 44: 1323-1389.
13. Dunn TB (1979). Tumors of the adrenal gland. IARC Sci Publ 23: 475-485.
14. Enerbäck L. (1974). Berberine sulfate binding to mast cell polyamines: A cytofluorometric method for the quantitation of heparin. Histochemistry 42: 301-313.
15. Faccini JM, Abbott DP, Paulus Gjj (1990). Mouse Histopathology—A Glossary for Use in Toxicity and Carcinogenicity Studies. Elsevier, Amsterdam, pp 171-177.
16. Foreman JC (1993). Introduction to mast cells and basophils. In: Immunopharmacology of Mast Cells and Basophils, Foreman JC (ed). Academic Press, London, pp 1-4.
17. Galli SJ (1990). New insights into “the riddle of the mast cells”: Microenvironmental regulation of mast cell development and phenotypic heterogeneity. Lab Invest 62: 5-33.
18. Galli SJ, Gordon JR, Wershil BK (1991). Cytokine production by mast cells and basophils. Curr Opin Immunol 3: 865-872.
19. Galli SJ, Zsebo KM, Geissler EN (1994). The c-kit ligand, stem cell factor. Adv Immunol 55: 1-96.
20. Galli SJ, Tsai M., Wershil BK, Tam SY, Costa JJ (1995). The regulation of mouse and human mast cell development, survival and function by stem cell factor, the ligand for the c-kit receptor. Int Arch Allergy Immunol 107: 51-53.
21. Ghildyal N., Friend DS, Freelund R., Austen KF, McNeil HP, Schiller V., Stevens RL (1994). Lack of expression of the tryptase mouse mast cell protease 7 in mast cells of the C57BL/6J mouse. J Immunol 153: 2624-2630.
22. Ghildyal N., Friend DS, Nicodemus CF, Austen KF, Stevens RL (1993). Reversible expression of mouse mast cell protease 2 mRNA and protein in cultured mast cells exposed to IL-10. J Immunol 151: 3206-3214.
23. Goodmann DG (1983). Subcapsular-cell hyperplasia, adrenal, mouse. In: Monographs on Pathology of Laboratory Animals—Endocrine System, Jones TC, Mohr U, Hunt RD (eds). Springer-Verlag, Berlin, pp 66-68.
24. Gordon JR, Burd PR, Galli SJ (1990). Mast cells as a source of multifunctional cytokines. Immunol Today 11: 458-464.
25. Gordon JR, Galli SJ (1990). Mast cells as a source of both preformed and immunologically inducible TNF-α/cachectin. Nature 346: 274-276.
26. Gordon JR, Galli SJ (1991). Release of both preformed and newly synthesized tumor necrosis factor α (TNF-α)/cachectin by mouse mast cells stimulated by the Fc∈RI. A mechanism for the sustained action of mast-cell-derived TNF-α during IgE-dependent biological responses. J Exp Med 174: 103-107.
27. Gordon JR, Galli SJ (1994). Promotion of mouse collagen gene expression by mast cells stimulated via the Fc∈RI: Role for mast cell-derived transforming growth factor-β and tumor necrosis factor-α. J Exp Med 180: 2027-2037.
28. Gospodarowicz D. (1989). Fibroblast growth factor. Crit Rev Oncogene 1: 1-26.
29. Gospodarowicz D., Ferrara N., Schweigerer L., Neufeld G. (1987). Structural characterization and biological functions of fibroblast growth factor. Endocr Rev 8: 95-114.
30. Hafez MM, Costlow ME (1988). Prolactin binding and localization in rat mammary tumor mast cells. Cancer Res 48: 3765-3771.
31. Horigome K., Bullock EO, Johnson EM Jr (1994). Effects of nerve growth factor on rat peritoneal mast cells. Survival promotion and immediate early gene induction. J Biol Chem 269: 2695-2702.
32. Hunt JE, Stevens RL, Austen KF, Zhang J., Xia Z., Ghildyal N. (1996). Natural disruption of the mouse mast cell protease 7 gene in the C57BL/6 mouse. J Biol Chem 271: 2851-2855.
33. Iemura A., Tsai M., Ando A., Wershil BK, Galli SJ (1994). The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144: 321-328.
34. Kawamoto K., Okada T., Kannan Y., Ushio H., Matsumoto M., Matsuda H. (1995). Nerve growth factor prevents apoptosis of rat peritoneal mast cells through the trk proto-oncogene receptor. Blood 86: 4638-4644.
35. Kendal JC, Li XH, Galli SJ, Gordon JR (1997). Promotion of mouse fibroblast proliferation by IgE-dependent activation of mouse mast cells: Role for mast cell tumor necrosis factor-α and transforming growth factor-β1. J Allergy Clin Immunol 99: 113-123.
36. Kim JS, Kubota H., Doi K., Saegusa J. (1997). Correlation of mast cells with spindle cell hyperplasia in the adrenal cortex of IQI/Jic mice. Exp Anim 46: 103-109.
37. Kim JS, Kubota H., Kiuchi Y., Doi K., Saegusa J. (1997). Subcapsular cell hyperplasia and mast cell infiltration in the adrenal cortex of mice: Comparative study in 7 inbred strains. Exp Anim 46: 303-306.
38. Kitamura Y. (1989). Heterogeneity of mast cells and phenotypic changes between subpopulations. Annu Rev Immunol 7: 59-76.
39. Kitamura Y., Go S., Hatanaka K. (1978). Decrease of mast cells in W/Wv mice and their increase by bone marrow transplantation. Blood 52: 447-452.
40. Klagsbrun M. (1992). Mediators of angiogenesis: The biological significance of basic fibroblast growth factor (bFGF)-heparin and heparin sulfate interactions. Cancer Biol 3: 81-87.
41. Leslie CC, McCormick-Shannon K., Mason RJ (1990). Heparin-binding growth factors stimulate DNA synthesis in rat alveolar type II cells. Am J Respir Cell Mol Biol 2: 99-106.
42. Lindner V., Reidy MA (1991). Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 88: 3739-3743.
43. Matsuda H., Kannan Y., Ushio H., Kiso Y., Kanemoto T., Suzuki H., Kitamura Y. (1991). Nerve growth factor induces development of connective tissue-type mast cells in vitro from murine bone marrow cells. J Exp Med 174: 7-14.
44. McNeil HP, Reynolds DS, Schiller V., Ghildyal N., Gurley DS, Austen KF, Stevens RL (1992). Isolation, characterization, and transcription of the gene encoding mouse mast cell protease 7. Proc Natl Acad Sci USA 89: 11174-11178.
45. Meininger CJ, Zetter BR (1992). Mast cells and angiogenesis. Semin Cancer Biol 3: 73-79.
46. Metcalfe DD, Baram D., Mekori YA (1997). Mast cells. Physiol Rev 77: 1033-1079.
47. Nadel JA (1991). Biology of mast cell tryptase and chymase. Ann NY Acad Sci 629: 319-331.
48. Nakahata T., Spicer SS, Cantry JR, Ogawa M. (1982). Clonal assay of mouse mast cell colonies in methylcellulose culture. Blood 60: 352-361.
49. Norrby K. (1994). Basic fibroblast growth factor and de novo mammalian angiogenesis. Microvasc Res 48: 96-113.
50. Norrby K., Eneström S. (1984). Cellular and extracellular changes following mast-cell secretion in avascular rat mesentery. An electron-microscopic study. Cell Tissue Res 235: 339-345.
51. Qu Z., Liebler JM, Powers MR, Galey T., Ahmadi P., Huang XN, Ansel JC, Butterfield JH, Planck SR, Rosenbaum JT (1995). Mast cells are a major source of basic fibroblast growth factor in chronic inflammation and cutaneous hemangioma. Am J Pathol 147: 564-573.
52. Ruoss SJ. Hartman T., Caughey GH (1991). Mast cell tryptase is a mitogen for cultured fibroblasts. J Clin Invest 88: 493-499.
53. Schollmeier K. (1990). Immunologic and pathophysiologic role of tumor necrosis factor. Am J Respir Cell Mol Biol 3: 11-12.
54. Schwartz LB (1994). Tryptase: A mast cell serine protease. Methods Enzymol 244: 88-100.
55. Tsai M., Takeishi T., Thompson H., Langley KE, Zsebo KM, Metcalfe DD, Geissler EN, Galli SJ (1991). Induction of mast cell proliferation, maturation and heparin synthesis by the rat c-kit ligand, stem cell factor. Proc Natl Acad Sci USA 88: 6382-6386.
56. Williams DE, Eisenman J., Baird A., Rauch C., Ness KV, March CJ, Park LS, Martin U., Mochizuki D., Boswell HS, Burgess GS, Cos-man D., Lyman SD (1990). Identification of ligand for the c-kit proto-oncogene. Cell 63: 167-174.
57. Williams N., Bertoncello I., Kavnoudias H., Zsebo K., McNiece I. (1992). Recombinant rat stem cell factor stimulates the amplification and differentiation of fractionated mouse stem cell populations. Blood 79: 58-64.
58. Woolley GW (1950). Experimental endocrine tumors with special reference to the adrenal cortex. Recent Prog Horm Res 5: 383-405.
59. Zsebo KM, Williams DA, Geissler EN, Broudy VC, Martin FH, Atkins HL, Hsu RY, Birkett NC, Okino KH, Murdock DC, Jacobsen FW, Langley KE, Smith KA, Takeishi T., Cattanach BM, Galli SJ, Suggs SV (1990). Stem cell factor (SCF) is encoded at the Sl locus of the mouse and is the ligand for the c-kit tyrosine kinase receptor. Cell 63: 213-224.